Captor Therapeutics S.A. (CTX)
Market Closed
15 Oct, 02:50 PM
WSE 
zł
58. 40
-1.2
-2.0134%
zł
- Market Cap
- P/E Ratio
- Div Yield
26,322 Volume
- Eps
zł 59.6
Previous Close Want to track CTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Captor Therapeutics S.A. (CTX) Statistics
Valuation metrics
Market Cap -
Enterprise value 405.59M
Trailing P/E (ttm) -8.25
Forward P/E -
PEG ratio 2.37
Price/Sales (ttm) 202.06
Price/Book (mrq) 6.18
Enterprise Value/Revenue 202.19
Enterprise Value/EBITDA -8.83
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.66K
Average volume (90 days) 3.42K
Price summary
52-Week low 38
52-Week high 89.2
Beta -
50-Day moving average 70.67
200-Day moving average 75.15
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -22.08%
Operating margin -25.34%
Operational effectiveness
Return on assets -0.56%
Return on equity -1.32%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.32
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.39
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 5.41%
Book value per share (mrq) 10.36
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
